Pharmaceutical Co stories:
Japanese Stocks Fall as Profit Outlook Casts Doubt on Recovery
Nov 12th, 2009 - Bloomberg
Nov. 12 (Bloomberg) -- Japanese stocks fell as losses atEbara Corp. and Alps Electric Co. overshadowed signals thatcentral banks around the world will keep borrowing costs low tosupport economic growth. Ebara...
Takeda Agrees to Buy Rights to Amylin's Obesity Drugs
Nov 2nd, 2009 - Bloomberg
Nov. 2 (Bloomberg) -- Japan’s Takeda Pharmaceutical Co.,maker of the world’s top-selling diabetes treatment, will pay asmuch as $1 billion to Amylin Pharmaceuticals Inc...Amylin Pharmaceuticals signs obesity drug deal with Takeda potentially worth over $1 billion
Nov 2nd, 2009 - ChicagoTribune
NEW YORK (AP) - Amylin Pharmaceuticals Inc. says it could potentially receive more than $1 billion from a partnership with Japan's Takeda Pharmaceutical Co. on potential obesity treatments. Amylin...
Abbott Said to Near $7.6 Billion to Buy Solvay Unit
Sep 27th, 2009 - Bloomberg
Sept. 27 (Bloomberg) -- Abbott Laboratories is close to anagreement to buy Solvay SA’s pharmaceutical unit for as much as5.2 billion euros ($7.6 billion) to get full control of theTriCor cholesterol pill...
Japan's Takeda to buy IDM Pharma in cancer drug push
May 18th, 2009 - Reuters
*To pay $2.64 cash per IDM Pharma share, 55 pct premium *Acquisition gives Takeda bone cancer drug approved in Europe TOKYO, May 18 (Reuters) - Takeda Pharmaceutical Co Ltd(4502.T)...



